Glaucoma

Segui
Researchers at the University of Missouri in a lab studying agmatine and thiamine as biomarkers for early glaucoma detection, with vials and eye scans visible.
Immagine generata dall'IA

Mizzou researchers identify molecules for early glaucoma detection

Riportato dall'IA Immagine generata dall'IA Verificato

Scientists at the University of Missouri report that two natural molecules — agmatine and thiamine — are reduced in samples from glaucoma patients and could serve as early biomarkers. In preclinical work, the compounds also showed signs of protecting retinal cells, suggesting a path to earlier detection and potential neuroprotective therapies.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta